Literature DB >> 26824439

Genetics of Type 2 Diabetes.

Alena Stančáková, Markku Laakso.   

Abstract

Genetic and environmental factors as well as their interactions contribute to the pathogenesis of type 2 diabetes. Linkage analysis, candidate gene approaches, genome-wide association studies, and sequencing have been used in the identification of common, low-frequency and rare variants for type 2 diabetes. Genome-wide association studies have identified >80 common variants for type 2 diabetes, with small effect sizes (risk of type 2 diabetes increased by 5-40%). Almost all of these variants regulate insulin secretion, and only a few regulate insulin sensitivity. Common variants capture only ∼10% of the heritability of type 2 diabetes. Low-frequency and rare variants with large effects have also been identified, but their contribution to 'missing heritability' at the population level is limited. Gene-environment and gene-gene interactions and epigenetics are likely to contribute to the missing heritability of type 2 diabetes. Epigenetic factors (DNA methylations and histone modifications) are especially important because they might mediate the effects of environmental exposures on the risk of type 2 diabetes. Although understanding of the genetics of type 2 diabetes has exhibited great progress in the past few years, a substantial amount of additional work will be required to identify causal variants/genes and molecular mechanisms via which the association signals found confer diabetes risk.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 26824439     DOI: 10.1159/000439418

Source DB:  PubMed          Journal:  Endocr Dev        ISSN: 1421-7082


  24 in total

1.  Genetic risk scores in the prediction of plasma glucose, impaired insulin secretion, insulin resistance and incident type 2 diabetes in the METSIM study.

Authors:  Alena Stančáková; Teemu Kuulasmaa; Johanna Kuusisto; Karen L Mohlke; Francis S Collins; Michael Boehnke; Markku Laakso
Journal:  Diabetologia       Date:  2017-06-01       Impact factor: 10.122

2.  Effects of the TCF7L2 and KCNQ1 common variant on sulfonylurea response in type 2 diabetes mellitus patients: a preliminary pharmacogenetic study.

Authors:  Diba Dianatshoar; Tara Alidaee; Negar Sarhangi; Mahdi Afshari; Hamid Reza Aghaei Meybodi; Mandana Hasanzad
Journal:  J Diabetes Metab Disord       Date:  2022-01-11

3.  A pharmacogenetic pilot study of CYP2C9 common genetic variant and sulfonylureas therapeutic response in type 2 diabetes mellitus patients.

Authors:  Elham Didari; Negar Sarhangi; Mahdi Afshari; Hamid Reza Aghaei Meybodi; Mandana Hasanzad
Journal:  J Diabetes Metab Disord       Date:  2021-09-14

4.  The epidemiology, clinical, biochemical, immunological and radiological features of youth onset type 2 diabetes mellitus in the state of Qatar.

Authors:  Shayma M Ahmed; Basma Haris; Saras Saraswathi; Ahmed Elawwa; Amal Khalifa; Maryam AlMaadheed; Tasneem R Abdel-Karim; Noor Hamed; Houda Afyouni; Hajar Dauleh; Ahmed Shamekh; Mahmoud Al-Zyoud; Fawziya AlKhalaf; Goran Petrovski; Khalid Hussain
Journal:  Diabetol Int       Date:  2021-10-11

5.  Is type 2 diabetes mellitus another intercellular junction-related disorder?

Authors:  Carla B Collares-Buzato; Carolina Pf Carvalho
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-23

Review 6.  Understanding childhood diabetes mellitus: new pathophysiological aspects.

Authors:  Juergen Grulich-Henn; Daniela Klose
Journal:  J Inherit Metab Dis       Date:  2017-12-15       Impact factor: 4.982

7.  Neuroimaging endophenotypes of type 2 diabetes mellitus: a discordant sibling pair study.

Authors:  Dong Zhang; Lin Shi; Xiubao Song; Changzheng Shi; Pan Sun; Wutao Lou; Defeng Wang; Liangping Luo
Journal:  Quant Imaging Med Surg       Date:  2019-06

8.  KCNQ1 common genetic variant and type 2 diabetes mellitus risk.

Authors:  Taraneh Erfani; Negar Sarhangi; Mahdi Afshari; Davood Abbasi; Hamid Reza Aghaei Meybodi; Mandana Hasanzad
Journal:  J Diabetes Metab Disord       Date:  2019-12-08

9.  The APOE4 allele is associated with a decreased risk of retinopathy in type 2 diabetics.

Authors:  Lucie Dlouha; Terezie Pelikanova; Jiří Veleba; Vera Adamkova; Vera Lanska; Tomas Sosna; Lukas Pacal; Katerina Kankova; Jaroslav A Hubacek
Journal:  Mol Biol Rep       Date:  2021-07-30       Impact factor: 2.316

10.  Elevation in fibroblast growth factor 23 and its value for identifying subclinical atherosclerosis in first-degree relatives of patients with diabetes.

Authors:  Xiang Hu; Xiaojing Ma; Yuqi Luo; Yiting Xu; Qin Xiong; Xiaoping Pan; Yuqian Bao; Weiping Jia
Journal:  Sci Rep       Date:  2016-10-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.